More like first-trimester-of-pregnancy food aversion energy
June 21st, 2024: Mass tort lawsuit in Philadelphia challenges 15 million Americans' GLP-1 drug safety A mass tort lawsuit is currently underway in a federal court in Philadelphia, addressing serious concerns regarding the safety and regulatory oversight of widely used weight-loss medications including Ozempic, Wegovy, Rybelsus, Trulicity, and Mounjaro
Key Takeaways GLP-1 medications can make staying hydrated more important by affecting appetite and, for some people, causing temporary gastrointestinal side effects
As always, talk to a licensed provider to make sure any treatment plan is right for you
These lawsuits claim that the companies failed to adequately warn consumers about the potentially severe side effects and health complications associated with their drugs
Yes, injecting GLP-1 medications above the belly button is generally acceptable and falls within FDA-approved guidelines for abdominal injection sites
